Max Healthcare Institute Limited
NSE:MAXHEALTH.NS
984.85 (INR) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 15,429.5 | 14,229 | 13,349.7 | 13,631.6 | 12,849.9 | 12,179.7 | 11,412.4 | 11,371.2 | 10,662.7 | 8,905.3 | 9,741.6 | 10,183.3 | 10,001.7 | 7,796 | 7,956 | 6,509.4 | 2,562.7 | 10,505.4 | 2,671 | 2,805.5 | 7,190 | 1,969.35 | 1,969.35 | 6,640 | 6,410 | 6,660 |
| Cost of Revenue
| 10,011.8 | 9,003.1 | 2,672.8 | 2,797.9 | 2,758.5 | 460.7 | 2,298.3 | 2,263.3 | 2,197.8 | 1,998.2 | 2,094.4 | 2,532.6 | 2,603.8 | 1,759.7 | 1,915 | 1,617.5 | 651.9 | 2,290.1 | 539.3 | 547.1 | 5,000 | 350.55 | 350.55 | 4,520 | 4,640 | 4,500 |
| Gross Profit
| 5,417.7 | 5,225.9 | 10,676.9 | 10,833.7 | 10,091.4 | 11,719 | 9,114.1 | 9,107.9 | 8,464.9 | 6,907.1 | 7,647.2 | 7,650.7 | 7,397.9 | 6,036.3 | 6,041 | 4,891.9 | 1,910.8 | 8,215.3 | 2,131.7 | 2,258.4 | 2,190 | 1,618.8 | 1,618.8 | 2,120 | 1,770 | 2,160 |
| Gross Profit Ratio
| 0.351 | 0.367 | 0.8 | 0.795 | 0.785 | 0.962 | 0.799 | 0.801 | 0.794 | 0.776 | 0.785 | 0.751 | 0.74 | 0.774 | 0.759 | 0.752 | 0.746 | 0.782 | 0.798 | 0.805 | 0.305 | 0.822 | 0.822 | 0.319 | 0.276 | 0.324 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 3.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 3,275.3 | 2,925.5 | 2,760.6 | 2,772.5 | 2,710.3 | 2,620 | 2,425.5 | 2,445 | 2,372.6 | 3,176 | 2,112.1 | 2,025.5 | 1,768.3 | 2,176.5 | 1,679.5 | 1,392.6 | 583.9 | 3,077.9 | 601.2 | 639.4 | 310 | 350 | 350 | 340 | 340 | 360 |
| Selling & Marketing Expenses
| -962.7 | -811.7 | 0 | 0 | 0 | 575.5 | 0 | 0 | 0 | 446.2 | 0 | 0 | 0 | 167.5 | 0 | 0 | 0 | 254.5 | 0 | 0 | 1,130 | 108.55 | 108.55 | 1,130 | 1,140 | 1,160 |
| SG&A
| 2,312.6 | 2,113.8 | 2,760.6 | 2,772.5 | 2,710.3 | 2,620 | 2,425.5 | 2,445 | 2,372.6 | 3,622.2 | 2,112.1 | 2,025.5 | 1,768.3 | 2,344 | 1,679.5 | 1,392.6 | 583.9 | 3,332.4 | 601.2 | 639.4 | 1,440 | 1,085.4 | 1,085.4 | 1,470 | 1,480 | 1,520 |
| Other Expenses
| 37.3 | 70.6 | 54.2 | 41.5 | 52.4 | -756.2 | 451.5 | 258.2 | 315.1 | -336.6 | 288.7 | 114.2 | 75.6 | -765 | 395.2 | 403.2 | 11.5 | -125.3 | 105.8 | 39.2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 2,312.6 | 2,113.8 | 7,427.9 | 7,539 | 7,275.8 | 6,884.5 | 6,549.9 | 6,495.5 | 6,392.6 | 4,848.7 | 5,741.3 | 5,798.9 | 5,491.8 | 4,285.3 | 4,923.9 | 4,588.4 | 2,417 | 6,827.3 | 2,022.2 | 2,091.9 | 1,800 | 2,134.85 | 2,134.85 | 1,850 | 1,850 | 1,850 |
| Operating Income
| 3,105.1 | 3,112.1 | 3,709.2 | 3,749.5 | 2,815.6 | 3,202.1 | 3,015.7 | 2,870.6 | 2,072.3 | 1,883.5 | 1,905.9 | 1,851.8 | 2,392 | 1,847.5 | 1,117.1 | 706.7 | 1,512.3 | 1,751.8 | 215.3 | 205.7 | 390 | 194.55 | 194.55 | 270 | -90 | 310 |
| Operating Income Ratio
| 0.201 | 0.219 | 0.278 | 0.275 | 0.219 | 0.263 | 0.264 | 0.252 | 0.194 | 0.212 | 0.196 | 0.182 | 0.239 | 0.237 | 0.14 | 0.109 | 0.59 | 0.167 | 0.081 | 0.073 | 0.054 | 0.099 | 0.099 | 0.041 | -0.014 | 0.047 |
| Total Other Income Expenses Net
| 108 | 245.2 | -112.4 | -85.3 | 219.3 | -195.3 | -201.3 | -218.4 | 91.5 | -339.6 | 224.5 | -35.6 | -261.6 | -802.8 | -68.2 | -532.4 | -463.4 | -890.9 | -271.7 | -208.8 | -350 | 57.05 | 57.05 | -330 | -270 | -320 |
| Income Before Tax
| 3,213.1 | 3,357.3 | 3,596.8 | 3,664.2 | 3,034.9 | 3,006.8 | 2,814.4 | 2,652.2 | 2,163.8 | 1,543.9 | 2,130.4 | 1,816.2 | 1,898.5 | 1,044.7 | 1,048.9 | 174.3 | -3,001.7 | 860.9 | -56.4 | -3.1 | 40 | 251.6 | 251.6 | -60 | -360 | -10 |
| Income Before Tax Ratio
| 0.208 | 0.236 | 0.269 | 0.269 | 0.236 | 0.247 | 0.247 | 0.233 | 0.203 | 0.173 | 0.219 | 0.178 | 0.19 | 0.134 | 0.132 | 0.027 | -1.171 | 0.082 | -0.021 | -0.001 | 0.006 | 0.128 | 0.128 | -0.009 | -0.056 | -0.002 |
| Income Tax Expense
| 850.4 | 841.9 | 703.4 | 897.4 | 634.1 | 497.6 | 590.3 | -1,921.3 | 435.5 | 306.6 | 232.9 | 369.7 | 429.3 | 347.8 | 145.3 | 43.2 | -89.7 | -61.3 | -0.2 | -0.5 | 20 | 27.55 | 27.55 | 10 | 10 | 20 |
| Net Income
| 2,362.7 | 2,515.4 | 2,893.4 | 2,766.8 | 2,400.8 | 2,509.2 | 2,224.1 | 4,573.5 | 1,728.3 | 1,237.3 | 1,897.5 | 1,446.5 | 1,469.2 | 696.9 | 903.6 | 131.1 | -3,142.5 | 895 | -18 | -13.6 | 20 | 209.95 | 209.95 | -70 | -370 | -30 |
| Net Income Ratio
| 0.153 | 0.177 | 0.217 | 0.203 | 0.187 | 0.206 | 0.195 | 0.402 | 0.162 | 0.139 | 0.195 | 0.142 | 0.147 | 0.089 | 0.114 | 0.02 | -1.226 | 0.085 | -0.007 | -0.005 | 0.003 | 0.107 | 0.107 | -0.011 | -0.058 | -0.005 |
| EPS
| 2.43 | 2.59 | 2.98 | 2.85 | 2.47 | 2.58 | 2.29 | 4.72 | 1.78 | 1.27 | 1.98 | 1.5 | 1.52 | 0.77 | 1 | 0.18 | -3.47 | 1.97 | -0.04 | -0.03 | 0 | 0.39 | 0 | 0 | 0 | 0 |
| EPS Diluted
| 2.42 | 2.58 | 2.97 | 2.84 | 2.46 | 2.58 | 2.29 | 4.71 | 1.78 | 1.27 | 1.96 | 1.49 | 1.51 | 0.77 | 1 | 0.18 | -3.47 | 1.97 | -0.04 | -0.03 | 0 | 0.39 | 0 | 0 | 0 | 0 |
| EBITDA
| 3,874.1 | 3,815.3 | 4,318.8 | 4,328.3 | 3,787 | 3,805.6 | 3,586 | 3,447.4 | 2,958.7 | 2,364.7 | 2,944.4 | 2,703.6 | 2,701.5 | 2,323.1 | 1,996.5 | 1,273.4 | -51.4 | 2,610.4 | 323.3 | 313.1 | 628.425 | 432.975 | 430.6 | 506.05 | 146.05 | 548.775 |
| EBITDA Ratio
| 0.251 | 0.268 | 0.324 | 0.318 | 0.295 | 0.312 | 0.314 | 0.303 | 0.277 | 0.266 | 0.302 | 0.265 | 0.27 | 0.298 | 0.251 | 0.196 | -0.02 | 0.248 | 0.121 | 0.112 | 0.087 | 0.22 | 0.219 | 0.076 | 0.023 | 0.082 |